Education
About Us
Working with TipRanks
Follow Us
ViaDerma (VDRM)
OTHER OTC:VDRM
VDRM Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.02
Previous CloseN/A
Volume2.73M
Average Volume (3M)581.10K
Market Cap
$1.23M
Enterprise Value$6.39M
Total Cash (Recent Filing)$10.24K
Total Debt (Recent Filing)$322.94K
Price to Earnings (P/E)―
Beta-1.66
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding1,233,713,100
10 Day Avg. Volume428,867
30 Day Avg. Volume581,103
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap5.18
Enterprise Value/Revenue14.17
Enterprise Value/Gross Profit14.17
Enterprise Value/Ebitda-48.89
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
VDRM FAQ
What was ViaDerma’s price range in the past 12 months?
ViaDerma lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is ViaDerma’s market cap?
ViaDerma’s market cap is $1.23M.
When is ViaDerma’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ViaDerma’s earnings last quarter?
Currently, no data Available
Is ViaDerma overvalued?
According to Wall Street analysts ViaDerma’s price is currently Overvalued.
Does ViaDerma pay dividends?
ViaDerma does not currently pay dividends.
What is ViaDerma’s EPS estimate?
ViaDerma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ViaDerma have?
ViaDerma has 1,233,713,100 shares outstanding.
What happened to ViaDerma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of ViaDerma?
Currently, no hedge funds are holding shares in VDRM
Company Description
ViaDerma
ViaDerma, Inc. (VDRM) is a specialty pharmaceutical company focused on developing and marketing innovative drug delivery systems. The company primarily operates in the healthcare sector, providing topical products that utilize its proprietary technology to enhance the delivery and effectiveness of active ingredients. ViaDerma's core product, Vitastem, is a topical antibiotic aimed at treating skin infections and wounds more efficiently than traditional methods.
ViaDerma (VDRM) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Aurinia Pharmaceuticals
―
Cidara Therapeutics
―
Aclaris Therapeutics
―
Purple Biotech
―
Journey Medical Corp
―